Mira Pharmaceuticals Inc
MIRA
Get informed when a big investor buys or sells
+ FollowMarket Cap$31.1M
Close$
$0.27
64.3% downside
Current Fair Value
64.3% downsideOvervalued by 64.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $31.10 Million |
|---|---|
| Enterprise Value | $27.49 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.35 |
| Beta | 1.49 |
| Outstanding Shares | 41,941,370 |
Return
| Return on Equity | -380.24% |
|---|---|
| Return on Assets | -378.35% |
| Return on Invested Capital | 41.48% |
Valuation & Multiples
| P/E Ratio | -0.51 |
|---|---|
| PEG | 2.4 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 8.12 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 2, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.12%▼ 4.24% |
|---|---|
| Total Invested | $2.30M▼ 31.38% |
| Investors Holding | 26▲ 1.00% |
ESG Score
No data